P26196 (DDX6_HUMAN) Homo sapiens (Human)
Probable ATP-dependent RNA helicase DDX6 UniProtKBInterProSTRINGInteractive Modelling
483 aa; Sequence (Fasta) ;
16 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
9 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| CNOT1 MIF4G domain - DDX6 complex |
Heteromer A5YKK6; | 3×MG; | ||||
| Assess | ||||||
| Structure of a human 4E-T - DDX6 - CNOT1 complex |
Heteromer A5YKK6; Q9NRA8; | |||||
| Assess | ||||||
| Extended structure of the human DDX6 C-terminal domain in complex with an EDC3 FDF peptide |
Heteromer Q96F86; | 5×PO4; 3×CXS; | ||||
| Assess | ||||||
| Crystal structure of the C-terminal RecA domain of DDX6 in complex with a conserved peptide from LS… |
Heteromer Q9XW17; | 4×SO4; | ||||
| Assess | ||||||
| Structure of the human DDX6 C-terminal domain in complex with an EDC3- FDF peptide |
Heteromer Q96F86; | 3×CXS; 3×PO4; | ||||
| Assess | ||||||
| Structure of the human DDX6 C-terminal domain in complex with an EDC3- FDF peptide |
Heteromer Q96F86; | 3×GOL; | ||||
| Assess | ||||||
| Complex of human DDX6 (RECA-C) and CNOT1 (MIF4G) |
Heteromer A5YKK6; | 7×GOL; | ||||
| Assess | ||||||
| DDX6 | monomer | 1×ACT; | ||||
| Assess | ||||||
| Crystal structure of the N-terminal domain of rck/p54, a human DEAD-box protein | monomer | 1×ZN; | ||||
| Assess | ||||||
8 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4ct4.1.B | monomer | 0.84 | 2×MG; | 100.00 | ||
| Assess | ||||||
| 4ct5.1.A | monomer | 0.83 | 100.00 | |||
| Assess | ||||||
| 4brw.1.A | monomer | 0.83 | 69.68 | |||
| Assess | ||||||
| 4c9b.1.A | monomer | 0.76 | 38.54 | |||
| Assess | ||||||
| 4kbf.1.A | monomer | 0.74 | 34.26 | |||
| Assess | ||||||
| 4kbf.2.A | monomer | 0.73 | 34.26 | |||
| Assess | ||||||
| 2hxy.1.A | monomer | 0.73 | 38.54 | |||
| Assess | ||||||
| 4kbg.2.A | monomer | 0.72 | 34.26 | |||
| Assess | ||||||